Biodexa Pharmaceuticals

NASDAQ: BDRX · Real-Time Price · USD
7.08
0.04 (0.57%)
At close: Aug 15, 2025, 3:59 PM
7.00
-1.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Biodexa Pharmaceuticals Cash Flow Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-5.73M -6.82M -7.08M -8.16M -7.66M -5.37M -5.46M -7.92M
Depreciation & Amortization
254K 276K 283K 304K 343K 406K 403K 833K
Stock-Based Compensation
283K 163K 28K 38K 123K 152K 89K 38K
Other Working Capital
2.24M n/a -207K -42K 157K -8K n/a 50K
Other Non-Cash Items
-3.08M -336K -216K 139K -22K -1.77M -553K 1.55M
Deferred Income Tax
-250K n/a -118K -372K -130K -300K 398K -165K
Change in Working Capital
-3.74M -1.04M 158K 292K 164K 140K -487K 177K
Operating Cash Flow
-12.26M -7.75M -6.83M -7.39M -7.05M -6.44M -6.01M -5.32M
Capital Expenditures
-774K -22K -26K -33K -62K -164K -320K -309K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-589K -1.02M -239K -150K -158K 16K 42K 2.82M
Investing Cash Flow
-598K -1.04M -265K -183K -220K -148K -278K 2.52M
Debt Repayment
245K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 8.62M 10.23M 6.38M 47K 8.81M 8.8M 2.62M
Financial Cash Flow
8.56M 8.62M 10.23M 6.38M 47K 8.81M 8.8M 2.62M
Net Cash Flow
n/a 5.43M 1.57M -598K 4.63M 9.35M 1.26M -62K
Free Cash Flow
-13.04M -7.77M -6.85M -7.42M -7.11M -6.6M -6.33M -5.63M